Reviving Vitamin E Studies That Challenge Claims of Wonder Supplement Also Leave Openings

The last year hasn't been a good one for vitamin E.Analyzing data from the Women's Health Study, a
Once considered a wonder supplement, antrial involving 40,000 women who got either 600 IU
inexpensive and harmless pill that might prevent heartof vitamin E every other day or a placebo,
disease, cancer and Alzheimer's, a flurry of recentresearchers found that it provided no overall
clinical trials suggest it does none of those things.cardiovascular benefit such as reduction in heart
Some even suggest there is a small chance it couldattacks or strokes.
be harmful in higher doses.However, an analysis of a subgroup of women over
Yet while the oily little capsule apparently can't keep65 found a 26% reduction in cardiovascular events.
people alive longer, it refuses to die, in part becauseBuring said that although the finding was "intriguing," it
in nearly every one of the recent negative studieswas not supported by previous research.
some caveat or contradictory finding creates aShe added that it needs confirmation.
glimmer of hope.Adding even more confusion, the study found a
It also doesn't hurt that the dietary supplementstatistically significant 24% reduction in cardiovascular
industry continues to promote vitamin E and offersdeaths among all the vitamin E users.
experts to refute some of new research.Buring also questioned that finding because there was
"It doesn't go away," said Edgar Miller, a vitamin Eno overall reduction in strokes and heart attacks. She
researcher and associate professor of medicine atsaid it was possible that it was due to other
Johns Hopkins University. "Why does it keep sellingcardiovascular causes such as arrhythmias or heart
when there are so many of these negative studies?"failure, but there was no reasonable biological
The answer appears to be a combination of factors,explanation for that.
including years of promising laboratory, animal and"People should look at that further, but it could be
epidemiological studies; heavy promotion by thechance," she said.
dietary supplement industry; and, more recently,Buring concluded that vitamin E was neither harmful
contradictory findings within studies showing nonor beneficial in preventing cardiovascular disease.
overall benefit.A surprise
The required daily amount is 22 IU (international units).About a week after the Women's Health Study,
Many recent clinical trials have ranged from 300 IU toanother controversial vitamin E finding was presented.
2,000 IU.The study involved 9,500 people aged 55 and older
Recent clinical trials of high-dose vitamin E have ledwith vascular disease or diabetes who were followed
some researchers to speculate that vitamin E infor an average of seven years.
megadoses may increase the oxidation of LDLIt found that 400 IU of vitamin E a day provided no
cholesterol, the bad kind.protection against cancer or major vascular events
When cholesterol is oxidated, it contributes tosuch as heart attacks or strokes.
coronary artery disease.In addition, the study found a disturbing 13% increase
There also is some concern that high amounts ofin heart failure cases and 21% increase in heart failure
vitamin E may displace other beneficial anti-oxidantshospitalizations.
from that average person's diet.That was the first time that vitamin E had been
Combining studiesassociated with an increased risk of heart failure, said
Consider these recent studies: In November, alead author Eva Lonn, a professor of medicine at
vitamin E bombshell was dropped by Johns HopkinsMcMaster University in Hamilton, Ontario.
University researchers at an American Heart"I am not convinced about the harm," Lonn added.
Association meeting.Indeed, a recent small study of heart failure patients
They pooled 19 clinical trials of vitamin E involvingtaking a cholesterol-lowering statin drug suggested
136,000 patients.that vitamin E actually increased the statin's ability to
In 11 of the high-dose trials (400 IU or more), the riskimprove blood vessel function and lower inflammation.
of dying from any cause increased 4%, comparedLonn and the other researchers said a review of all
with people taking placebos.heart failure events in large vitamin E clinical trials "is
Prior to that finding, vitamin E had been considered,strongly recommended."
at worst, harmless.Confounding the heart failure finding was what
"People take anti-oxidants because they want to liveappeared to be a statistically significant 28%
longer," said Miller, an associate professor of medicine.reduction in lung cancer cases, although in a
"What we showed is you don't live longer."secondary analysis of the data the benefit seemed
However, the analysis also suggested that lowerto disappear.
doses of vitamin E (less than 150 I.U. a day) were"The numbers are small," Lonn said. "We think it's a
associated with about a 2% reduction in deaths.chance finding."
Researchers acknowledged several potentialThe researchers noted that other larger vitamin E
shortcomings in their study.trials showed no lung cancer benefit.
For instance, they noted that several of theAlzheimer's research
high-dose trials involved people with various chronicThere still is some hope that vitamin E might help
diseases and may not apply to healthy individuals.prevent Alzheimer's disease, although in May a clinical
They also said the small size of several of the trials intrial of 769 patients with mild cognitive impairment
the analysis and inconsistent reporting of healthfound it was of no benefit in delaying the progression
events prevented a detailed look at the effect ofto Alzheimer's.
various doses of the vitamin.In that trial, the patients took a mega dose 2,000 IU
"It's a very flawed analysis," said Julie Buring, aa day for up to three years, according to the findings
professor of medicine at Harvard Medical School whoin the New England Journal of Medicine.
recently presented her own vitamin E research.Other vitamin E / Alzheimer's trials are ongoing.
She also said the 4% increased risk of death wasThe anti-oxidant vitamin enthusiasm of the 1990s is
not "clinically meaningful" and could be a chancebeing tempered by clinical trials, according to a JAMA
finding.editorial that accompanied the Women's Health Study
Women's health studyresults.
On March 7, Buring and other Harvard scientists"These hopes are now confined to modest
presented their own vitamin E study at the Americanexpectations for specific disorders and there are
College of Cardiology annual meeting.concerns about adverse effects," the editorial said.
Once again, the vitamin threw researchers a curve.